全部股东
股东类型
- 公众及其他63.13%
- 个人与内部人士16.33%
- 员工持股计划10.59%
- 风投/私募8.43%
- 机构投资者1.51%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
Wenzhi TianFounder, CEO, Chief Scientific Officer & Chairman of the Board | 16.33% | 7,048.30 万 | 0.01% | +5.00 万 | |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP | 10.59% | 4,570.11 万 | 0.00% | +0 | |
Shanghai Yongkan Investment Management Co., Ltd. | 8.43% | 3,639.23 万 | 0.00% | +0 | |
GF Fund Management Co., Ltd. | 0.76% | 327.72 万 | 0.00% | +0 | |
E Fund Management Co., Ltd. | 0.41% | 178.04 万 | 0.00% | +0 | |
State Street Investment Management | 0.22% | 97.04 万 | <0.01% | +3.12 万 | |
Zhong Ou Fund Management Co., Ltd | 0.09% | 39.90 万 | 0.00% | +0 | |
Fullgoal Fund Management Co. Ltd. | 0.02% | 8.86 万 | 0.00% | +0 | |
Dimensional Fund Advisors LP | <0.01% | 1.88 万 | <0.01% | +2,067.00 |